Cyxone AB (publ) announced that Carl-Magnus Högerkorp is appointed new COO in the company from May 20th, 2021. With broad experience from work within the field of immunology and autoimmune diseases, as well as extensive international experience and previous management roles in the biotech sector, Carl-Magnus is an important part of Cyxone's continued ambition to strengthen and develop the company. Carl-Magnus takes over the role as COO from Malin Berthold, who is leaving the company.